Branning Todd P. 4
4 · NeuBase Therapeutics, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Branning Todd P.
Chief Financial Officer
Transactions
- Purchase
Common stock
2022-03-17$1.74/sh+10,000$17,400→ 20,000 total - Purchase
Common stock
2022-03-16$1.62/sh+10,000$16,200→ 10,000 total